These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12778840)

  • 1. Outcome predictors in substance use disorders.
    Ciraulo DA; Piechniczek-Buczek J; Iscan EN
    Psychiatr Clin North Am; 2003 Jun; 26(2):381-409. PubMed ID: 12778840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpharmacologic approaches to substance abuse treatment.
    Carroll KM; Schottenfeld R
    Med Clin North Am; 1997 Jul; 81(4):927-44. PubMed ID: 9222261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social anxiety spectrum.
    Schneier FR; Blanco C; Antia SX; Liebowitz MR
    Psychiatr Clin North Am; 2002 Dec; 25(4):757-74. PubMed ID: 12462859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
    Genung V
    Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The one-year prospective prediction of substance abuse and dependence among high-risk adolescents.
    Sussman S; Dent CW; Leu L
    J Subst Abuse; 2000; 12(4):373-86. PubMed ID: 11452840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.
    Forster SE; DePhilippis D; Forman SD
    J Subst Abuse Treat; 2019 May; 100():64-83. PubMed ID: 30898330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent substance use disorders and comorbidity.
    Simkin DR
    Pediatr Clin North Am; 2002 Apr; 49(2):463-77. PubMed ID: 11993293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability and predictors of treatment-seeking for substance use disorders in the U.S.
    Blanco C; Iza M; Rodríguez-Fernández JM; Baca-García E; Wang S; Olfson M
    Drug Alcohol Depend; 2015 Apr; 149():136-44. PubMed ID: 25725934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Addiction and personality].
    Franques P; Auriacombe M; Tignol J
    Encephale; 2000; 26(1):68-78. PubMed ID: 10875064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of premorbid cognitive abilities to substance users' problems at treatment intake and improvements with substance abuse treatment and case management.
    Block RI; Bates ME; Hall JA
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):515-38. PubMed ID: 14510038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analgesic abuse and psychiatric comorbidity in headache patients].
    Radat F; Irachabal S; Swendsen J; Henry P
    Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes.
    Weinstock J; Alessi SM; Petry NM
    Drug Alcohol Depend; 2007 Mar; 87(2-3):288-96. PubMed ID: 17005329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to treatment in children and adolescents with mood disorders.
    Emslie GJ; Mayes TL; Laptook RS; Batt M
    Psychiatr Clin North Am; 2003 Jun; 26(2):435-56. PubMed ID: 12778842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality, drug of choice, and comorbid psychopathology among substance abusers.
    Conway KP; Swendsen JD; Rounsaville BJ; Merikangas KR
    Drug Alcohol Depend; 2002 Feb; 65(3):225-34. PubMed ID: 11841894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.